SCHEMBL7366258

SCHEMBL7366258

CCOC(=O)c1cccnc1Oc1ccc(F)c(C#N)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.52
GPR55 Q9Y2T6 2/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 4/20 0.48
TDP1 Q9NUW8 3/20 0.48
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
SLC22A12 Q96S37 1/20 0.45
ATM Q13315 1/20 0.44
NPC1 O15118 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.43
P2RX3 P56373 1/20 0.43
RAB9A P51151 1/20 0.43
HSD17B10 Q99714 1/20 0.42
ROCK2 O75116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7369514 0.87 CARM1 (0.52) L3MBTL1KMT2AALDH1A1TDP1SMN1; SMN2
SCHEMBL7367004 0.84 SLC22A12 (0.47) KMT2AALDH1A1TDP1SLC22A12RAB9A
SCHEMBL850967 0.82 ELANE (0.53) L3MBTL1GPR55KMT2AMEN1NPSR1
SCHEMBL7373877 0.81 ELANE (0.53) L3MBTL1GPR55ALDH1A1KDM4ETDP1
SCHEMBL3578614 0.81 KDM4E (0.48) L3MBTL1GPR55KMT2AMEN1NPSR1
SCHEMBL3454518 0.81 POLB (0.61) L3MBTL1GPR55KMT2AMEN1NPSR1
SCHEMBL7370199 0.80 TDP1 (0.52) L3MBTL1KMT2AMEN1NPSR1ALDH1A1
SCHEMBL7372704 0.79 NPC1 (0.54) L3MBTL1KMT2AALDH1A1TDP1SMN1; SMN2
SCHEMBL8560540 0.78 GAA (0.62) L3MBTL1KMT2AMEN1NPSR1ALDH1A1
SCHEMBL3454297 0.78 CYP1A2 (0.62) L3MBTL1KMT2AALDH1A1TDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380218-B1 FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL PFIZER INC 2002-04-30 US disclosed
EP-0971894-A1 NICOTINAMIDE DERIVATIVES Pfizer Products Inc. (US) 2000-01-19 EP disclosed
WO-1998045268-A1 NICOTINAMIDE DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-10-15 WO disclosed